By a GenomeWeb staff reporter

This article has been updated from a previous version to include comments from company officials.

NEW YORK (GenomeWeb News) – Genomic Health reported after the close of the market Wednesday that its second-quarter revenues increased 19 percent year over year, and the firm posted its first-ever quarterly profit.

However, citing "market and economic conditions," the firm lowered its revenue and earnings guidance for the year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.